Services     

Commercialization of Novel Biomarkers

Novel biomarkers face both scientific as well as market challenges that all need to be overcome to achieve commercial success. Rx Dx Advisors can help you:

  • Evaluate the current evidence for the clinical utility of the proposed biomarker
  • Design and execute publishable biomarker validation studies
  • Select the optimal assay platform for biomarker commercilaization
  • Develop a go-to-market strategy to educate prescribing physicians and insurance providers on how to use the new biomarker assay to improve patient care

News & Updates

Get Updated at AMP in Salt Lake City

Coming to the Association for Molecular Pathology meeting... LEARN MORE >


San Diego – A Powerhouse Genomics Hub

The San Diego Economic Development Corp. just published &... LEARN MORE >


More News >

RxDx Advisors, Inc., San Diego, CA  //   Privacy Policy   //   San Diego Website Design